These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23552405)

  • 1. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.
    Gökmen MR; Cosyns JP; Arlt VM; Stiborová M; Phillips DH; Schmeiser HH; Simmonds MS; Cook HT; Vanherweghem JL; Nortier JL; Lord GM
    Ann Intern Med; 2013 Mar; 158(6):469-77. PubMed ID: 23552405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
    Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
    Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    De Broe ME
    Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours.
    Pfohl-Leszkowicz A
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):465-83. PubMed ID: 20061248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.
    Jadot I; Declèves AE; Nortier J; Caron N
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balkan endemic nephropathy: an update on its aetiology.
    Stiborová M; Arlt VM; Schmeiser HH
    Arch Toxicol; 2016 Nov; 90(11):2595-2615. PubMed ID: 27538407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
    Grollman AP
    Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy.
    de Jonge H; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jan; 23(1):39-41. PubMed ID: 17913731
    [No Abstract]   [Full Text] [Related]  

  • 10. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.
    Jelaković B; Dika Ž; Arlt VM; Stiborova M; Pavlović NM; Nikolić J; Colet JM; Vanherweghem JL; Nortier JL
    Semin Nephrol; 2019 May; 39(3):284-296. PubMed ID: 31054628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aristolochic acid nephropathy: a worldwide problem.
    Debelle FD; Vanherweghem JL; Nortier JL
    Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.
    Stefanovic V; Polenakovic M; Toncheva D
    Pathol Biol (Paris); 2011 Oct; 59(5):286-91. PubMed ID: 19896305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbs and hazards: risk of aristolochic acid nephropathy in Iran.
    Ardalan MR; Khodaie L; Nasri H; Jouyban A
    Iran J Kidney Dis; 2015 Jan; 9(1):14-7. PubMed ID: 25599730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
    Luciano RL; Perazella MA
    Drug Saf; 2015 Jan; 38(1):55-64. PubMed ID: 25446374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
    Arlt VM; Ferluga D; Stiborova M; Pfohl-Leszkowicz A; Vukelic M; Ceovic S; Schmeiser HH; Cosyns JP
    Int J Cancer; 2002 Oct; 101(5):500-2. PubMed ID: 12216081
    [No Abstract]   [Full Text] [Related]  

  • 17. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants.
    Jelaković B; Vuković Lela I; Karanović S; Dika Ž; Kos J; Dickman K; Šekoranja M; Poljičanin T; Mišić M; Premužić V; Abramović M; Matijević V; Miletić Medved M; Cvitković A; Edwards K; Fuček M; Leko N; Teskera T; Laganović M; Čvorišćec D; Grollman AP
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):215-23. PubMed ID: 25587102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aristolochic Acids as Persistent Soil Pollutants: Determination of Risk for Human Exposure and Nephropathy from Plant Uptake.
    Li W; Chan CK; Liu Y; Yao J; Mitić B; Kostić EN; Milosavljević B; Davinić I; Orem WH; Tatu CA; Dedon PC; Pavlović NM; Chan W
    J Agric Food Chem; 2018 Oct; 66(43):11468-11476. PubMed ID: 30286603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of exposure analysis in solving the mystery of Balkan endemic nephropathy.
    Long DT; Voice TC
    Croat Med J; 2007 Jun; 48(3):300-11. PubMed ID: 17589972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.